TY - JOUR
AU - A. Locke
AU - N. Kamo
A1 - 
AB - Access to mental health providers has become an increasingly common challenge for many patients with depression and anxiety disorders. Primary care providers often manage this gap in care and currently provide solo care without the assistance of other team members. In order to provide quality care that aligns with best practice, we developed a depression and anxiety disorder treatment pathway utilizing a multidisciplinary team based on each members' individual skill set, or skill-task alignment. The main change to treatment implemented by the pathway was the addition of a clinical pharmacist in the management of patient care. This pathway was trialed over five months targeting two adult primary care teams (approximately 34 physicians and Advanced Registered Nurse Practitioners [ARNPs]) while the other five teams continued with current practice standards. Post-implementation metrics indicated that clinical pharmacists successfully contacted 55% (406 of 738) of patients started on medication or who had a medication changed. Of these patients reached, 82 (20%) had an intervention completed. In addition, all physician leaders on the planning team (n=6) stated the new pathway was well received and delivered positive feedback from team members.
BT - BMJ quality improvement reports
C5 - Education & Workforce
CP - 1
CY - England
DO - 10.1136/bmjquality.u211816.w4748
IS - 1
JF - BMJ quality improvement reports
N2 - Access to mental health providers has become an increasingly common challenge for many patients with depression and anxiety disorders. Primary care providers often manage this gap in care and currently provide solo care without the assistance of other team members. In order to provide quality care that aligns with best practice, we developed a depression and anxiety disorder treatment pathway utilizing a multidisciplinary team based on each members' individual skill set, or skill-task alignment. The main change to treatment implemented by the pathway was the addition of a clinical pharmacist in the management of patient care. This pathway was trialed over five months targeting two adult primary care teams (approximately 34 physicians and Advanced Registered Nurse Practitioners [ARNPs]) while the other five teams continued with current practice standards. Post-implementation metrics indicated that clinical pharmacists successfully contacted 55% (406 of 738) of patients started on medication or who had a medication changed. Of these patients reached, 82 (20%) had an intervention completed. In addition, all physician leaders on the planning team (n=6) stated the new pathway was well received and delivered positive feedback from team members.
PP - England
PY - 2016
SN - 2050-1315
SP - 10.1136/bmjquality.u211816.w4748. eCollection 2016
T1 - Utilizing clinical pharmacists to improve delivery of evidence-based care for depression and anxiety in primary care
T2 - BMJ quality improvement reports
TI - Utilizing clinical pharmacists to improve delivery of evidence-based care for depression and anxiety in primary care
U1 - Education & Workforce
U2 - 27493753
U3 - 10.1136/bmjquality.u211816.w4748
VL - 5
VO - 2050-1315
Y1 - 2016
ER -